Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alpha Teknova (TKNO) Cash & Equivalents (2020 - 2025)

Alpha Teknova (TKNO) has disclosed Cash & Equivalents for 6 consecutive years, with $5.9 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 59.44% to $5.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.9 million through Dec 2025, up 59.44% year-over-year, with the annual reading at $5.9 million for FY2025, 59.44% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $5.9 million at Alpha Teknova, up from $3.2 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $108.0 million in Q2 2021, with the low at $3.2 million in Q3 2025.
  • Average Cash & Equivalents over 5 years is $36.1 million, with a median of $26.1 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents soared 2540.06% in 2021, then tumbled 86.98% in 2024.
  • Over 5 years, Cash & Equivalents stood at $87.5 million in 2021, then tumbled by 51.74% to $42.2 million in 2022, then plummeted by 32.56% to $28.5 million in 2023, then crashed by 86.98% to $3.7 million in 2024, then surged by 59.44% to $5.9 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $5.9 million, $3.2 million, and $3.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.